Starling Oncology, Inc. (STLN)
The Oncology Institute provides outpatient cancer care, specialty pharmacy and clinical trial services from Cerritos, California. It last closed at $3.40 on Nov 17, down 3.95% on the day. The average 12-month price target from 4 analysts is $9.25 (+172.1% from the last close), with a high of $10.00 and a low of $8.00. Analyst consensus is Strong Buy, based on the latest ratings from 4 firms (4 buy, 0 hold, 0 sell). Over the past 90 days StreetAlpha recorded 1 whale options trade in STLN, 100% of them bullish and 0% bearish. In the past 30 days there were 1 dark pool print totaling $163K, the largest $163K.
Key Stats
Last 12 monthsNot reported for this period.
From STLN's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 6). Last 12 months adds up the four latest quarters.
Earnings
Full earnings history →Analyst Ratings & Price Targets
Analyst Ratings →Based on 4 analysts who set a price target on STLN in the past 90 days. The average target is $9.25, with a high of $10.00 and a low of $8.00, compared with the last close of $3.40.
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Nov 9 | BTIG | Reiterated | Buy | $10 |
| Nov 7 | Lake Street | Maintained | Buy | $8 |
| Nov 6 | B. Riley Securities | Reiterated | Buy | $10 |
| Nov 6 | BTIG | Maintained | Buy | $10 |
| Oct 14 | Needham | Maintained | Buy | $9 |
Technical Analysis
The stock is 61% below its 20 day and 80% below its 50 day average. Momentum is weak (RSI 29), oversold. The nearest support is the swing low (Nov 6) at $3.35, and the nearest resistance the Pivot at $3.48.
| RSI (14) | 28.95 | Oversold below 30 | Oversold |
| MACD | -0.80 | Below its signal line | Bearish |
| Stochastic | 4.6 | Near the bottom of its range | Oversold |
| ADX (14) | 33.8 | Trending down | |
| Williams %R | -97.6 | Oversold below −80, overbought above −20 | Oversold |
| CCI (20) | -107.9 | Oversold below −100, overbought above 100 | Oversold |
| Rate of change | −46.4% | Change over 10 sessions | Bearish |
| ATR (14) | $0.55 | Typical daily range, 16.3% of price |
What happened before
See how STLN did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How STLN has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2020.
Whale Options Flow
90DNo whale options trades in STLN in the last 90 days.
Dark Pool
30DSTLN Institutional Ownership
Full report →- ▲73 buying vs 46 selling
- ▲Held by funds +2.9 pts
- ▲Funds holding +9
- ▲Superinvestors: 3 added, 1 cut
- ●Put/call not meaningful
| Q3 2026 | This quarter | Last quarter | Change |
|---|---|---|---|
| Funds holding | 129 | 120 | +7.5% |
| In funds' top 10 | 3 | 2 | +50.0% |
| Held by funds | 42.2% | 39.3% | +2.9 pts |
| New / increased | 26 / 47 | 27 / 51 | −6.4% |
| Reduced / sold out | 31 / 15 | 25 / 22 | −2.1% |
| Put/call ratio | – | – | – |
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether STLN is in one of them and how their past STLN trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered STLN in an article yet. Here's the latest on the wider market.
STLN Congress Trades
All congress trades →| Person | Type | Amount | Traded | Filed | Delay |
|---|---|---|---|---|---|
| Richard BlumenthalD · CT | Sell (partial) | $1K – $15K | Sep 23, 2026 | Oct 26, 2026 | 33 d |
| Richard BlumenthalD · CT | Sell (partial) | $1K – $15K | Sep 23, 2026 | Oct 26, 2026 | 33 d |
| Richard BlumenthalD · CT | Sell (partial) | $15K – $50K | Sep 22, 2026 | Oct 26, 2026 | 34 d |
| Richard BlumenthalD · CT | Sell (partial) | $15K – $50K | Sep 22, 2026 | Oct 26, 2026 | 34 d |
| Richard BlumenthalD · CT | Sell (partial) | $15K – $50K | Sep 22, 2026 | Oct 26, 2026 | 34 d |
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Starling Oncology
The Oncology Institute is a cancer care company based in Cerritos, California. It provides outpatient cancer treatment, including medical oncology, radiation oncology, infusion therapy and specialty pharmacy services, through clinics in five states. Its patients are mostly referred by other doctors and health plans. It is paid either for each service it delivers or by health plans under contracts that set a fixed amount per patient. It also runs clinical trial services for drug companies.
- Headquarters
- Cerritos, CA




